Meeting
2022 ASCO Genitourinary Cancers Symposium
Contemporary outcomes of a systematic prostate cancer active surveillance program: Results from the Niagara Health System, Ontario, Canada.
Authors
Aruz Mesci
McMaster University, Hamilton, ON, Canada
Aruz Mesci , Nicole Niki Tsakiridis , Mohammad Gouran-Savadkoohi , Brent Faught , Ian Brown , Theodoros Tsakiridis
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Quality of Care/Quality Improvement and Real-World Evidence
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 241)
DOI
10.1200/JCO.2022.40.6_suppl.241
Abstract #
241
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Patient-level factors associated with the use of active surveillance: The Talking About Prostate Cancer Cohort.
First Author: Nita Mukand
Poster
2018 Genitourinary Cancers Symposium
Evaluation of a predefined AS threshold in a large cohort of men with localized prostate cancer.
First Author: Daniel Canter
Poster
2014 ASCO Annual Meeting
Population-based analysis of treatment receipt in prostate cancer patients who initially pursued active surveillance (AS).
First Author: Nathan Christopher Sheets
Poster
2014 Genitourinary Cancers Symposium
Long-term treatment with testosterone undecanoate injections and its effect of prostate cancer incidence in hypogonadal men.
First Author: Ahmad Haider